Marianne Carlsen
Fox Chase Chemical Diversity Center(US)
Publications by Year
Research Areas
Biochemical and Molecular Research, HIV Research and Treatment, HIV/AIDS drug development and treatment, Adenosine and Purinergic Signaling, Sphingolipid Metabolism and Signaling
Most-Cited Works
- → Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)(2010)110 cited
- → Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders(2009)74 cited
- → Novel inhibitors of IMPDH(2003)27 cited
- → Tight-Binding Hydroxypyrazole HIV-1 Nef Inhibitors Suppress Viral Replication in Donor Mononuclear Cells and Reverse Nef-Mediated MHC-I Downregulation(2019)21 cited
- → Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation(2009)20 cited
- → Quinolone-Based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analogues(2003)10 cited
- → Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors(2009)10 cited
- → 5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase(2009)5 cited
- Onboarding i en bransje med høy turnover(2018)